Drug Type Natural Killer Cell Therapies |
Synonyms NK cell derived from human embryonic stem cells(Shanghai Vitalgen Biopharma), VGO-Cs01p |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD7 Positive T-Cell Leukemia | Phase 1 | - | 01 Feb 2025 | |
Refractory T Acute Lymphoblastic Leukemia | Phase 1 | - | 01 Feb 2025 |